Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
new york blog main
new york top stories
alirocumab
alnylam pharmaceuticals
amgen
biontech
biotech
boehringer ingelheim
boston
boston top stories
clinical trials
curevac
deals
drugs
eli lilly
evercore isi
evolocumab
heart attack
inclisiran
infectious diseases
john shiver
joseph swartz
medicines co.
moderna therapeutics
mrna
new york
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
san francisco blog main
san francisco top stories
sanofi
stroke
svb leerink
translate bio
umer raffat
vaccines
What
evidence
2
×
medicines
2
×
new
2
×
rna
alnylam
based
bets
bio
cancer
cholesterol
comes
companies
cut
data
date
deal
drug
effective
enticed
hasn’t
heart
lasting
latest
long
looms
lowering
medco
messenger
molecules
mrna
multiple
partner
pharmaceutical
pharmaceuticals
presented
primarily
promise
proven
reckoning
sanofi
Language
Current search:
evidence
×
new
×
medicines
×
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
